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Abstract 
Immunodeficient patients are at risk of developing extended or atypical herpes simplex 
virus infections, which can be easily misdiagnosed. We present the case of a 79-year-old, 
treatment-induced (oral corticosteroid), immunocompromised female with an extensive 
atypical herpes simplex virus infection. This patient presented with multiple erosions and 
vesicles on the trunk with a subacute onset. The clinical differential diagnosis was herpes 
simplex infection, herpes zoster infection, pemphigus vulgaris or bullous pemphigoid. 
Due to the atypical clinical presentation and negative Tzanck test, suspicion of viral 
infection was low. High-dose steroid treatment was initiated. Subsequent 
histopathology, however, showed a herpes simplex virus infection. After discontinuing 
steroid treatment and initiating antiviral treatment, the patient recovered within a week. 
Emphasis must be placed on the importance of clinical awareness of extended and 
clinically atypical herpes simplex infections in immunocompromised patients. A negative 
Tzanck test does not rule out the possibility of a herpes infection. 
 
Introduction 
Herpes simplex virus (HSV), a double-stranded DNA virus, is a common human 
pathogen, classically causing orofacial (mostly HSV-1) or genital (mostly HSV-2) 
infections [1]. The clinical presentation ranges from mild uncomplicated mucocutaneous 
infection to occasionally life-threatening, disseminated infection [2]. The pathogenesis 
follows the sequence of primary infection, latency in the local dorsal root ganglion of a 
sensory neuron, and reactivation [1, 2]. Of all human herpes viruses, HSV-1 infections are 
the most common. About 90% of individuals between 20 and 40 years old have been 
shown to have antibodies against HSV-1 [1]. Primary HSV-1 infections occur mainly in 
infancy or childhood and are usually mild or subclinical [1]. Later, the virus can be  
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reactivated spontaneously or by suppressed immunity, for example by trauma, fever, 
menstruation, ultraviolet radiation or immunosuppressive medication [1, 2]. 
Latent HSV may be reactivated by primary immunodeficiency or treatment-induced 
immune suppression. In these patients extensive skin involvement may occur with 
symptoms like malaise and fever. Atypical infections have been reported more frequently 
in immunocompromised patients than in immunocompetent hosts [3]. Also, cases of 
disseminated HSV infections with internal organ involvement (especially hepatitis) have 
been described in immunocompromised patients [4–7]. Both atypical and extended 
infections are associated with increased morbidity and mortality. 
Case Report 
A 79-year-old woman was referred to our out-patient dermatology department presenting with 
subacute onset, painful and itching blistering on the back. She was feeling ill, but had no fever. Her 
medical history mentioned an urothelial carcinoma which was treated by nephro-ureterectomy with 
lymph node dissection and adjuvant radiotherapy. Rectal blood loss due to mucosal radiation damage 
was treated by oral prednisone (20 mg daily) maintenance therapy. Furthermore, her medical history 
mentioned atrial fibrillation, hypertension, depression, and arthrosis. Her medication listed carbasalate 
calcium, amiodarone, citalopram, domperidone, esomeprazole, fentanyl, ferrofumarate, furosemide, 
lactulose, lorazepam, nadroparin, oxycodone, paracetamol, and spironolactone. History of previous 
orofacial herpes infections was unknown. 
Clinically, multiple eroded vesicles and blisters with minimal surrounding erythema were seen on 
the back. The lesions were located mostly on the left side of the back within a disseminated distribution 
(fig. 1). Two crusted erosions were present on the thorax and nose; the oral mucosa was not affected. 
The clinical differential diagnosis was herpes simplex infection, herpes zoster infection, pemphigus 
vulgaris or bullous pemphigoid. Tzanck test, taken from the base of a vesicle, was negative. The clinical 
working diagnosis was autoimmune blistering disorder due to the atypical distribution of the skin 
lesions and negative Tzanck test. The patient was treated with oral prednisone (1 mg/kg/day) and class 
IV topical corticosteroids. 
Two days later, histopathology showed intra-epidermal blistering with multinucleated keratinocytes 
with ground glass nuclei and acantholysis. Immunohistochemistry with polyclonal antibodies against 
HSV-1 and HSV-2 was positive. Immunofluorescence was negative for autoimmune blistering 
disorders. Upon the diagnosis herpes simplex infection, oral and topical steroid treatment was 
discontinued and oral aciclovir (1,000 mg 3 times daily) and local zinc oxide were initiated. The skin 
lesions improved within a week. 
Discussion 
HSV infections have been reported more often in immunocompromised patients than 
in immunocompetent hosts [3].Generalized or atypical HSV infections have been 
described in pregnant women, neonates, with oral corticosteroid immune suppression 
and immunosuppression after kidney or bone marrow transplantation [8]. These 
infections usually are a reactivation of a previous HSV infection [3]. Characteristics of 
atypical infections in immunocompromised patients include: larger size of lesions, deeper 
ulceration, satellite lesions, longer healing time, HSV shedding in the saliva, and atypical 
locations [3]. Atypical HSV infections in immunocompromised patients may resemble 
autoimmune blistering disorders like pemphigus vulgaris, pemphigus foliaceus or bullous 
pemphigoid. Herpes zoster infection must also be considered in the differential diagnosis. 
Atypical HSV infections mimicking autoimmune blistering disorders can cause 
diagnostic delay and delayed or incorrect treatment.  
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Although the diagnosis of HSV infections is usually made clinically, Tzanck test, 
electron microscopy, viral culture and polymerase chain reaction (PCR) detection of HSV 
DNA can be utilized to verify the diagnosis [2, 9]. In our case, the atypical clinical 
presentation and negative Tzanck test discouraged the initial clinical diagnose of a HSV 
infection, resulting in the initial working diagnosis of autoimmune blistering disorder. 
The Tzanck test (or direct smear) is an easy, fast, and inexpensive diagnostic test to verify 
a clinical cutaneous HSV infection [9]. Sensitivity rates have been reported to be in the 
range of 73–100%. This rate is inferior to diagnostic tools like PCR and dependent upon 
doctors’ experience. Also, the type and duration of the lesions evaluated are important for 
the accuracy of the Tzanck test. Optimal lesions are fresh, intact blisters of 1–3 days’ 
duration. If blisters are absent, wet or eroded lesions are preferred to crusted lesions [9]. 
Our negative Tzanck test could be explained by suboptimal lesions (crusted and eroded 
blisters). 
Immunohistochemical staining, using polyclonal antibodies with cross-reactivity 
between HSV-1 and HSV-2 cannot differentiate between HSV-1 and HSV-2. In our case, 
HSV-1 infection is most likely, because of the co-existence of orofacial crustae. 
Unfortunately no PCR was performed to confirm HSV-1 infection.  
Conclusion 
This case report emphasises the importance of clinical awareness of the occurrence of 
extensive and atypical mucocutaneous HSV infections in immunocompromised patients. 
Furthermore, a negative Tzanck test does not rule out the presence of a HSV infection. 
 
 
 
 
 
Fig. 1. Eroded vesicles and blisters with minimal surrounding erythema on the back. 
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